How much is Jade Biosciences worth in 2026?

Jade Biosciences has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Jade Biosciences raised?

Jade Biosciences has raised N/A in total funding across 2 funding rounds.

Jade Biosciences

Biotechnology

Jade Biosciences valuation and funding history | Last updated: October 7, 2025 | 2 funding rounds

Current Valuation

N/A

As of October 7, 2025

Total Funding Raised

N/A

Across 2 rounds

Last Round

PIPE

$135.0M

Last Funding

Oct 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
October 7, 2025	PIPE	$135.0M	N/A	-
April 28, 2025	PIPE	$300.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Jade Biosciences is currently valued at N/A as of October 7, 2025.

Track Jade Biosciences Valuation Updates

Get notified when Jade Biosciences raises new funding or valuation changes

Explore More Data

Detailed analysis for Jade Biosciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Jade Biosciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is Jade Biosciences Worth in 2026?

Jade Biosciences is a leading private company in the Biotechnology sector. Track Jade Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Jade Biosciences Valuation is Determined

Private company valuations like Jade Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.